Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA451848
Max Phase: Preclinical
Molecular Formula: C40H59N5O6S
Molecular Weight: 738.01
Molecule Type: Small molecule
Associated Items:
ID: ALA451848
Max Phase: Preclinical
Molecular Formula: C40H59N5O6S
Molecular Weight: 738.01
Molecule Type: Small molecule
Associated Items:
Synonyms (1): KNI-10618
Synonyms from Alternative Forms(1):
Canonical SMILES: CCC(C)CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC(C)(C)[C@H]1C(=O)NCC(C)C)C(C)(C)C)c1ccccc1
Standard InChI: InChI=1S/C40H59N5O6S/c1-10-26(4)21-30(46)43-31(28-19-15-12-16-20-28)35(48)44-33(39(5,6)7)36(49)42-29(22-27-17-13-11-14-18-27)32(47)38(51)45-24-52-40(8,9)34(45)37(50)41-23-25(2)3/h11-20,25-26,29,31-34,47H,10,21-24H2,1-9H3,(H,41,50)(H,42,49)(H,43,46)(H,44,48)/t26?,29-,31-,32-,33+,34+/m0/s1
Standard InChI Key: YCJCCESGSIHYIN-KKMRILPTSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 738.01 | Molecular Weight (Monoisotopic): 737.4186 | AlogP: 4.35 | #Rotatable Bonds: 16 |
Polar Surface Area: 156.94 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 11 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.84 | CX Basic pKa: | CX LogP: 4.61 | CX LogD: 4.61 |
Aromatic Rings: 2 | Heavy Atoms: 52 | QED Weighted: 0.17 | Np Likeness Score: 0.32 |
1. Zhang M, Nguyen JT, Kumada HO, Kimura T, Cheng M, Hayashi Y, Kiso Y.. (2008) Synthesis and activity of tetrapeptidic HTLV-I protease inhibitors possessing different P3-cap moieties., 16 (10): [PMID:18400502] [10.1016/j.bmc.2008.03.055] |
Source(1):